Trials / Completed
CompletedNCT00067184
Fetal Neurobehavioral Development in Methadone Maintained Pregnancies
Methadone, Buprenorphine and Fetal Development
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 157 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine differences in fetal neurobehavior at peak (2 hours after oral dose) vs. trough (2 hours before oral dose) maternal plasma methadone levels.
Detailed description
This study will examine differences in fetal neurobehavior at peak (2 hours after oral dose) vs. trough (2 hours before oral dose) plasma methadone levels. Anecdotal clinical observations suggest that fetal activity is increased at trough methadone levels and decreased at peak methadone levels, yet the investigators do not understand how in utero methadone exposure affects fetal neurobehavioral state development.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Toitu 320/325 | Fetal monitor |
Timeline
- Start date
- 2002-09-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2003-08-13
- Last updated
- 2018-04-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00067184. Inclusion in this directory is not an endorsement.